Cedrik M. Britten
Chief Tech/Sci/R&D Officer bei IMMATICS N.V.
Vermögen: 2 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Cedrik M. Britten
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
104
| Public Company | Pharmaceuticals: Major | 104 |
Public Company | Biotechnology | 23 | |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Cedrik M. Britten
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Human Resources Officer Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Treasurer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member Chairman Director of Finance/CFO Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Corporate Officer/Principal | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
TESARO INC | Pharmaceuticals: Major | President Corporate Officer/Principal | |
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
University of Oxford | College/University | Graduate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree | |
University of Cambridge | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Cancer Research Institute
Cancer Research Institute Medical/Nursing ServicesHealth Services Cancer Research Institute provides cancer immunotherapy services. The private company is based in New York, NY and has subsidiaries in the United States. The company was founded in 1953. Jill O'Donnell-Tormey has been the CEO of the company since 1987. | Medical/Nursing Services | Corporate Officer/Principal Director/Board Member | |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
INSEAD | College/University | Masters Business Admin Director/Board Member Masters Business Admin Masters Business Admin | |
HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
University of Amsterdam | College/University | Graduate Degree Corporate Officer/Principal | |
The University of Nottingham | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
Eberhard Karls Universität Tübingen | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Hertfordshire | College/University | Undergraduate Degree Undergraduate Degree | |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
THOMSON REUTERS CORPORATION | Internet Software/Services | Director/Board Member Director/Board Member | |
dievini Hopp BioTech holding GmbH & Co. KG
dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Founder Chief Executive Officer | |
Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Febit, Inc. | Director/Board Member Chairman | ||
ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Investor Relations Contact General Counsel | |
Longwood Fund Management LLC
Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer Chief Executive Officer | ||
Molecular Health GmbH
Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The private company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Chairman Director/Board Member | |
Molecular Health, Inc.
Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
The Fuqua School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
The 100 Group
The 100 Group Miscellaneous Commercial ServicesCommercial Services The 100 Group is an organization that represents the views of finance directors from FTSE 100 and several large UK private companies. The private company is based in London, UK. The group is structured through committees that meet quarterly to discuss emerging topics on the agenda of finance directors. The main objective of the 100 Group is to promote the competitiveness of businesses. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman Chairman | |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Chairman Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Founder Director/Board Member Director/Board Member Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
Glaxosmithkline Australia Pty Ltd.
Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Glaxosmithkline Australia Pty Ltd. manufactures and markets prescription medicines, prescribed vaccines, and consumer healthcare products. It serves healthcare professionals and consumers. The company was founded in 1886 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
CONVATEC GROUP PLC | Medical Specialties | Chairman Director/Board Member | |
INFLARX N.V. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
The Rosalind Franklin Institute
The Rosalind Franklin Institute Miscellaneous Commercial ServicesCommercial Services The Rosalind Franklin Institute engages in research and technology development in life sciences. The private company is based in Didcot, UK. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member |
Statistik
International
Vereinigte Staaten | 20 |
Vereinigtes Königreich | 13 |
Deutschland | 10 |
Kanada | 3 |
Frankreich | 3 |
Sektoral
Health Technology | 23 |
Consumer Services | 11 |
Commercial Services | 9 |
Finance | 4 |
Technology Services | 4 |
Operativ
Director/Board Member | 525 |
Corporate Officer/Principal | 269 |
Independent Dir/Board Member | 144 |
Chairman | 133 |
Chief Executive Officer | 90 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Christof Hettich | 40 |
Anjali Bansal | 37 |
Friedrich von Bohlen und Halbach | 36 |
Eliot Forster | 35 |
Tom de Swaan | 35 |
Vindi Banga | 34 |
Saul Charles Klein | 33 |
Simon Dingemans | 31 |
Laurie Glimcher | 30 |
Deryck Charles Maughan | 27 |
Shah Hussain | 25 |
Iain Mackay | 25 |
Philip Hampton | 24 |
Andrew Witty | 24 |
Jonathan Symonds | 24 |
- Börse
- Insiders
- Cedrik M. Britten
- Unternehmensverbindungen